These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25337300)
1. Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature. Yang YQ; Fan L; Wang L; Xu J; Zhang R; Ge Z; Li JY; Xu W Int J Clin Exp Pathol; 2014; 7(9):6403-8. PubMed ID: 25337300 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
3. Hydroa Vacciniforme-Like EBV-Positive Cutaneous T-Cell Lymphoma, First Report of 2 Cases in Ecuador. Montalvo N; Redrobán L Am J Dermatopathol; 2016 May; 38(5):e57-9. PubMed ID: 26913846 [TBL] [Abstract][Full Text] [Related]
4. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171 [TBL] [Abstract][Full Text] [Related]
5. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation. Chen CC; Chang KC; Medeiros LJ; Lee JY J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children. Xu Z; Lian S Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358 [TBL] [Abstract][Full Text] [Related]
7. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Plaza JA; Sangueza M Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933 [TBL] [Abstract][Full Text] [Related]
8. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815 [TBL] [Abstract][Full Text] [Related]
9. Hydroa Vacciniforme-Like T-Cell Lymphoma: A Further Brazilian Case. Miranda MFR; Santos JEBD; Müller SFR; Bittencourt MJS; Brito AC; Barros Junior JNDS; Xerfan EMS Am J Dermatopathol; 2018 Mar; 40(3):201-204. PubMed ID: 28248720 [TBL] [Abstract][Full Text] [Related]
10. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases. Liu Y; Ma C; Wang G; Wang L J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082 [TBL] [Abstract][Full Text] [Related]
11. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults. Rodríguez-Pinilla SM; Barrionuevo C; Garcia J; Martínez MT; Pajares R; Montes-Moreno S; Casavilca S; Montes J; Bravo F; Zaharia M; Zevallos-Giampietri E; Sanchez L; Piris MA Am J Surg Pathol; 2010 Dec; 34(12):1773-82. PubMed ID: 21107082 [TBL] [Abstract][Full Text] [Related]
12. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review. Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199 [TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme-like lymphoproliferative disorder in Korea. Han B; Hur K; Ohn J; Kim TM; Jeon YK; Kim YC; Mun JH Sci Rep; 2020 Nov; 10(1):19294. PubMed ID: 33168864 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China. Huang W; Lv N; Ying J; Qiu T; Feng X Int J Clin Exp Pathol; 2014; 7(8):4991-9. PubMed ID: 25197370 [TBL] [Abstract][Full Text] [Related]
16. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases. Zhang Y; Liu Y; Xu J; Liang Y; Xu Z Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544 [TBL] [Abstract][Full Text] [Related]
17. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection. Chen CC; Chang KC; Medeiros LJ; Lee JY Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336 [TBL] [Abstract][Full Text] [Related]
18. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients. Xie Y; Wang T; Wang L J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634 [TBL] [Abstract][Full Text] [Related]
19. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721 [TBL] [Abstract][Full Text] [Related]
20. Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma. Lyapichev KA; Sukswai N; Wang XI; Khoury JD; Medeiros LJ Am J Dermatopathol; 2020 Sep; 42(9):714-716. PubMed ID: 31313696 [No Abstract] [Full Text] [Related] [Next] [New Search]